tiprankstipranks
Trending News
More News >
Moleculin Biotech Reports Positive Annamycin Trial Results
PremiumCompany AnnouncementsMoleculin Biotech Reports Positive Annamycin Trial Results
2d ago
Moleculin Biotech reports efficacy results from Phase 1B/2 trial of annamycin
Premium
The Fly
Moleculin Biotech reports efficacy results from Phase 1B/2 trial of annamycin
2d ago
Moleculin Biotech files to sell 10.99M shares of common stock, warrants
Premium
The Fly
Moleculin Biotech files to sell 10.99M shares of common stock, warrants
3d ago
Moleculin Biotech reports Q1 EPS (69c) vs ($2.02) last year
PremiumThe FlyMoleculin Biotech reports Q1 EPS (69c) vs ($2.02) last year
23d ago
Moleculin Biotech’s Annamycin Trial Approved by EMA
Premium
Company Announcements
Moleculin Biotech’s Annamycin Trial Approved by EMA
25d ago
Moleculin Biotech receives EMA approval to expand Phase 3 MIRACLE trial
Premium
The Fly
Moleculin Biotech receives EMA approval to expand Phase 3 MIRACLE trial
25d ago
MBRX Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsMBRX Upcoming Earnings Report: What to Expect?
1M ago
Moleculin Biotech Secures Two New U.S. Patents
Premium
Company Announcements
Moleculin Biotech Secures Two New U.S. Patents
1M ago
Moleculin Biotech announces granting of two new U.S. patents
Premium
The Fly
Moleculin Biotech announces granting of two new U.S. patents
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100